本页面由Tiger Trade Technology Pte. Ltd.提供服务

ADMA Biologics Inc

9.19
+0.08000.88%
盘前9.280.0900+0.98%09:13 EDT
成交量:612.65万
成交额:5,573.25万
市值:21.87亿
市盈率:15.32
高:9.26
开:8.90
低:8.80
收:9.11
52周最高:25.67
52周最低:7.21
股本:2.38亿
流通股本:2.34亿
量比:0.38
换手率:2.62%
股息:- -
股息率:- -
每股收益(TTM):0.6000
每股收益(LYR):0.6000
净资产收益率:35.56%
总资产收益率:21.50%
市净率:4.58
市盈率(LYR):15.32

数据加载中...

2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/08

重要事件披露

8-K - Current report
2023/01/17

重要事件披露

8-K - Current report
2022/12/09

重要事件披露

8-K - Current report
2022/12/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/07

重要事件披露

8-K - Current report
2022/12/06

重要事件披露

8-K - Current report
2022/11/09

重要事件披露

8-K - Current report
2022/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/31

重要事件披露

8-K - Current report
2022/08/10

重要事件披露

8-K - Current report
2022/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/22

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/07/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments